Additional Listing

Futura Medical PLC 31 January 2007 For immediate release 31 January 2007 Futura Medical Plc Additional Listing Futura Medical plc (the 'Company'), the AIM-listed pharmaceutical group that develops innovative products for consumer healthcare with expertise in sexual health, has applied for 50,000 new ordinary shares of 0.2p each in the Company to be admitted to trading on the AIM market of the London Stock Exchange. The shares are being issued following the exercise of options. The shares will rank pari passu with existing ordinary shares and dealings are expected to commence in the new ordinary shares at 8.00am on 5 February 2007. Pursuant to AIM Notice 26, the Company's total issued share capital following the anticipated admission of the shares as set out above is 55,353,601. For further information: Futura Medical plc www.futuramedical.co.uk James Barder, Chief Executive Tel: +44 (0) 1483 685 670 mail to: james.barder@futuramedical.co.uk Media enquiries: Buchanan Communications Mark Court Tel: +44 (0) 020 7466 5000 mail to: markc@buchanan.uk.com Rebecca Skye Dietrich mail to: rebeccad@buchanan.uk.com This information is provided by RNS The company news service from the London Stock Exchange